Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Eupraxia Pharmaceuticals (EPRX) vs. Competitors

48 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
EPRXEupraxia Pharmaceuticals$8.15$553.41M-7.8528.55%Strong BuyUnlock the EPRX analyst price target with TipRanks PremiumEPRXUnlock the EPRX top-analyst price target with TipRanks Premium
TSE:DRUGBright Minds BiosciencesCAD 32.75CAD 325.38M-11.29-60.16%Strong BuyUnlock the TSE:DRUG analyst price target with TipRanks PremiumEPRX vs TSE:DRUGUnlock the TSE:DRUG top-analyst price target with TipRanks Premium
TSE:MYNDMYND Life SciencesCAD 0.07CAD 3.35M-2.180.00%―Unlock the TSE:MYND analyst price target with TipRanks PremiumEPRX vs TSE:MYNDUnlock the TSE:MYND top-analyst price target with TipRanks Premium
TSE:MBIOMindbio Therapeutics Corp.CAD 0.10CAD 728.31K-0.05-93.33%―Unlock the TSE:MBIO analyst price target with TipRanks PremiumEPRX vs TSE:MBIOUnlock the TSE:MBIO top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
EPRXEupraxia Pharmaceuticals8.151.5523.48%
TSE:DRUGBright Minds Biosciences32.75-48.24-59.56%
TSE:MYNDMYND Life Sciences0.070.000.00%
TSE:MBIOMindbio Therapeutics Corp.0.10-1.15-92.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts